1-3 of 3
Doreen Hammerschmidt
Close
Sort by
Journal Articles

Outcomes Following Hypomethylating Agent / Venetoclax Combination-Therapy for MDS or AML Relapse after Allogeneic Hematopoietic Stem Cell Transplantation

Dominic Brauer, Lara Bischof, Jule Ussmann, Donata Backhaus, Georg-Nikolaus Franke, Vladan Vucinic, Marco Herling, Maximilian Merz, Leanthe Braunert, Doreen Hammerschmidt, Alexander Kühnemund, Anne Weigert, Klaus H. Metzeler, Uwe Platzbecker, Madlen Jentzsch, Sebastian Schwind
Journal: Blood
Blood (2022) 140 (Supplement 1): 4808–4809.
https://doi.org/10.1182/blood-2022-163363
Published: 2022
Journal Articles

Successful Stem Cell Mobilization and Autologous Stem Cell Transplantation after Pretreatment Consisting of Bendamustine, Prednisone and Bortezomib (BPV) in 35 Patients with Newly Diagnosed/Untreated Multiple Myeloma

Wolfram Poenisch, MD, Madlen Ploetze, Bruno Holzvogt, Marc Andrea, Thomas Zehrfeld, Doreen Hammerschmidt, Maik Schwarz, Thomas Edelmann, Cornelia Becker, Franz-Albert Hoffmann, Andreas Schwarzer, MD, Ute Kreibich, MD, Malvina Bourgeois, Simone Heyn, MD, Madlen Jentzsch, MD, Rainer Krahl, PhD, Sabine Leiblein, Thomas Schliwa, Vladan Vucinic, MD, Haifa Kathrin Al-Ali, MD, Gerhard Behre, MD, Thoralf Lange, MD, Dietger Niederwieser, MD
Journal: Blood
Blood (2014) 124 (21): 5900.
https://doi.org/10.1182/blood.V124.21.5900.5900
Published: 2014
Journal Articles

Successful Treatment with Bortezomib in Combination with Bendamustine and Prednisone of Patients with Newly Diagnosed/Untreated Multiple Myeloma and Light Chain Induced Renal Failure

Wolfram Pönisch, Marc Andrea, Ina Wagner, Doreen Hammerschmidt, Ute Kreibich, Andreas Schwarzer, MD, Thomas Zehrfeld, Maik Schwarz, Cornelia Winkelmann, Sirak Petros, Anette Bachmann, Tom Lindner, Dietger Niederwieser, MD
Journal: Blood
Blood (2011) 118 (21): 2938.
https://doi.org/10.1182/blood.V118.21.2938.2938
Published: 2011